Clinical trial
A Double-blind Randomized Placebo Controlled Comparison of Scopolamine With Cinnarizin for Prevention of Simulator Sickness
NCT01198106 is registered in ClinicalTrials.gov with Medical Corps, Israel Defense Force as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-blind Randomized Placebo Controlled Comparison of Scopolamine With Cinnarizin for Prevention of Simulator Sickness
- Lead sponsor
- Medical Corps, Israel Defense Force
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- September 30, 2009
- Completion date
- September 30, 2010
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
simulator sickness